TDAC
Translational Development Acquisition Corp. Ordinary Shares
NASDAQ: TDAC · FINANCIAL SERVICES · SHELL COMPANIES
$10.85
+0.09% today
Updated 2026-10-28
Market cap
$209.50M
P/E ratio
41.73
P/S ratio
—
EPS (TTM)
$0.26
Dividend yield
—
52W range
$10 – $11
Volume
0.0M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D6.5
Quality
B3.5
Profitability
D4.7
Valuation
C2/9
Piotroski F-Score
Weak
15.9
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →271 stocks currently score above 75
Price targets
Analyst target
$6.60
-39.17%
12-Month target
$6.60
-39.17%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Altman Z 15.89 — safe zone
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-338756.00
- P/E 41.73x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-70662.00 | $-485550.00 | $-71012.00 | $6.36M | $946982.00 |
| EPS | — | — | — | — | $0.26 |
| Free cash flow | $-97168.00 | $-204.00 | $-851450.00 | $-608390.00 | $-338756.00 |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Translational Development Acquisition Corp. Ordinary Shares trades at $10.85. representing a P/E of 41.73x trailing earnings. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 15.89, it sits in the safe zone.
Frequently asked questions
What is Translational Development Acquisition Corp. Ordinary Shares's stock price?
Translational Development Acquisition Corp. Ordinary Shares (TDAC) trades at $10.85, on a P/E of 41.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Translational Development Acquisition Corp. Ordinary Shares overvalued?
Translational Development Acquisition Corp. Ordinary Shares carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Translational Development Acquisition Corp. Ordinary Shares (TDAC)?
The 12-month analyst consensus target is $6.60, about 39.2% below the current $10.85. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Translational Development Acquisition Corp. Ordinary Shares's Altman Z-Score is 15.89, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorFINANCIAL SERVICES
IndustrySHELL COMPANIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE3.52%
Beta—
50D MA$10.84
200D MA$10.69
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—